SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-300284
Filing Date
2017-10-02
Accepted
2017-10-02 07:35:34
Documents
4
Period of Report
2017-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d406376d8k.htm 8-K 22087
2 EX-10.1 d406376dex101.htm EX-10.1 83204
3 EX-99.1 d406376dex991.htm EX-99.1 10410
4 GRAPHIC g406376g01n59.gif GRAPHIC 4786
  Complete submission text file 0001193125-17-300284.txt   123633
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 171113061
SIC: 2836 Biological Products, (No Diagnostic Substances)